B-intervention	0	7	Aerobic
I-intervention	8	11	and
I-intervention	12	22	Resistance
I-intervention	23	31	Exercise
O	32	40	Improves
B-condition	41	49	Shoulder
I-condition	50	58	Function
O	59	61	in
O	62	67	Women
O	68	71	Who
O	72	75	Are
O	76	86	Overweight
O	87	89	or
O	90	95	Obese
O	96	99	and
O	100	104	Have
O	105	111	Breast
O	112	118	Cancer
O	118	119	:
O	120	121	A
O	122	132	Randomized
O	133	143	Controlled
O	144	149	Trial
O	149	150	.

O	151	158	Adverse
O	159	164	upper
O	165	169	limb
O	170	185	musculoskeletal
O	186	193	effects
O	194	199	occur
O	200	205	after
O	206	214	surgical
O	215	225	procedures
O	226	229	and
O	230	242	radiotherapy
O	243	246	for
O	247	253	breast
O	254	260	cancer
O	261	264	and
O	265	268	can
O	269	278	interfere
O	279	283	with
O	284	294	activities
O	295	297	of
O	298	303	daily
O	304	310	living
O	310	311	.

O	312	315	The
O	316	325	objective
O	326	328	of
O	329	333	this
O	334	339	study
O	340	343	was
O	344	346	to
O	347	354	examine
O	355	358	the
O	359	366	effects
O	367	369	of
O	370	371	a
O	372	374	16
O	374	375	-
O	375	379	week
O	380	388	exercise
O	389	401	intervention
O	402	404	on
O	405	413	shoulder
O	414	422	function
O	423	425	in
B-eligibility	426	431	women
I-eligibility	432	435	who
I-eligibility	436	439	are
I-eligibility	440	450	overweight
I-eligibility	451	453	or
I-eligibility	454	459	obese
I-eligibility	460	463	and
I-eligibility	464	468	have
I-eligibility	469	475	breast
I-eligibility	476	482	cancer
O	482	483	.

O	484	488	This
O	489	494	study
O	495	498	was
O	499	500	a
O	501	511	randomized
O	512	522	controlled
O	523	528	trial
O	528	529	.

O	530	533	The
O	534	539	study
O	540	543	was
O	544	553	performed
O	554	556	at
O	557	560	the
O	561	569	Division
O	570	572	of
O	573	587	Biokinesiology
O	588	591	and
O	592	600	Physical
O	601	608	Therapy
O	609	611	at
O	612	615	the
O	616	626	University
O	627	629	of
B-location	630	638	Southern
I-location	639	649	California
O	649	650	.

B-total-participants	651	654	One
I-total-participants	655	662	hundred
O	663	668	women
O	669	673	with
O	674	680	breast
O	681	687	cancer
O	688	692	were
O	693	701	randomly
O	702	711	allocated
O	712	714	to
O	715	723	exercise
O	724	726	or
B-control	727	732	usual
I-control	732	733	-
I-control	733	737	care
O	738	744	groups
O	744	745	.

O	746	749	The
O	750	754	mean
O	755	756	(
O	756	758	SD
O	758	759	)
O	760	763	age
O	764	766	of
O	767	770	the
O	771	776	women
O	777	780	was
B-age	781	783	53
I-age	783	784	.
I-age	784	785	5
I-age	786	787	(
I-age	787	789	10
I-age	789	790	.
I-age	790	791	4
I-age	791	792	)
I-age	793	798	years
O	798	799	,
O	800	802	55
O	802	803	%
O	804	808	were
B-ethinicity	809	817	Hispanic
I-ethinicity	818	823	white
O	823	824	,
O	825	828	and
O	829	834	their
O	835	839	mean
O	840	841	(
O	841	843	SD
O	843	844	)
O	845	849	body
O	850	854	mass
O	855	860	index
O	861	864	was
O	865	867	33
O	867	868	.
O	868	869	5
O	870	871	(
O	871	872	5
O	872	873	.
O	873	874	5
O	874	875	)
O	876	878	kg
O	878	879	/
O	879	881	m2
O	881	882	.

O	883	886	The
O	887	889	16
O	889	890	-
O	890	894	week
O	895	903	exercise
O	904	916	intervention
O	917	926	consisted
O	927	929	of
O	930	940	supervised
O	940	941	,
O	942	953	progressive
O	953	954	,
O	955	963	moderate
O	964	966	to
O	967	975	vigorous
O	976	983	aerobic
O	984	987	and
O	988	998	resistance
O	999	1007	exercise
O	1008	1009	3
O	1010	1015	times
O	1016	1019	per
O	1020	1024	week
O	1024	1025	.

O	1026	1034	Shoulder
O	1035	1041	active
O	1042	1047	range
O	1048	1050	of
O	1051	1057	motion
O	1057	1058	,
O	1059	1068	isometric
O	1069	1077	muscular
O	1078	1086	strength
O	1086	1087	,
O	1088	1091	and
O	1092	1099	patient
O	1099	1100	-
O	1100	1108	reported
O	1109	1116	outcome
O	1117	1125	measures
O	1126	1127	(
O	1127	1136	including
O	1137	1149	Disabilities
O	1150	1152	of
O	1153	1156	the
O	1157	1160	Arm
O	1160	1161	,
O	1162	1170	Shoulder
O	1170	1171	,
O	1172	1175	and
O	1176	1180	Hand
O	1181	1184	and
O	1185	1188	the
O	1189	1193	Penn
O	1194	1202	Shoulder
O	1203	1208	Scale
O	1208	1209	)
O	1210	1214	were
O	1215	1223	assessed
O	1224	1226	at
O	1227	1235	baseline
O	1235	1236	,
O	1237	1242	after
O	1243	1246	the
O	1247	1259	intervention
O	1259	1260	,
O	1261	1264	and
O	1265	1267	at
O	1268	1271	the
O	1272	1273	3
O	1273	1274	-
O	1274	1279	month
O	1280	1286	follow
O	1286	1287	-
O	1287	1289	up
O	1290	1291	(
O	1291	1299	exercise
O	1300	1305	group
O	1306	1310	only
O	1310	1311	)
O	1311	1312	.

O	1313	1324	Differences
O	1325	1327	in
O	1328	1332	mean
O	1333	1340	changes
O	1341	1344	for
O	1345	1353	outcomes
O	1354	1358	were
O	1359	1368	evaluated
O	1369	1374	using
O	1375	1380	mixed
O	1380	1381	-
O	1381	1386	model
O	1387	1395	repeated
O	1395	1396	-
O	1396	1404	measures
O	1405	1413	analysis
O	1413	1414	.

O	1415	1423	Compared
O	1424	1428	with
O	1429	1432	the
O	1433	1438	usual
O	1438	1439	-
O	1439	1443	care
O	1444	1449	group
O	1449	1450	,
O	1451	1454	the
O	1455	1463	exercise
O	1464	1469	group
O	1470	1481	experienced
B-outcome	1482	1493	significant
I-outcome	1494	1503	increases
I-outcome	1504	1506	in
I-outcome	1507	1515	shoulder
I-outcome	1516	1522	active
I-outcome	1523	1528	range
I-outcome	1529	1531	of
I-outcome	1532	1538	motion
O	1539	1540	(
O	1540	1543	the
O	1544	1548	mean
O	1549	1556	between
O	1556	1557	-
O	1557	1562	group
O	1563	1574	differences
O	1575	1578	and
O	1579	1581	95
O	1581	1582	%
O	1583	1593	confidence
O	1594	1603	intervals
O	1604	1605	(
O	1605	1608	CIs
O	1608	1609	)
O	1610	1614	were
O	1615	1617	as
O	1618	1625	follows
O	1625	1626	:
B-outcome	1627	1635	shoulder
I-outcome	1636	1643	flexion
O	1644	1645	=
O	1646	1648	36
O	1648	1649	.
O	1649	1650	6
O	1650	1651	°
O	1652	1653	[
O	1653	1655	95
O	1655	1656	%
O	1657	1659	CI
O	1660	1661	=
O	1662	1664	55
O	1664	1665	.
O	1665	1666	2
O	1666	1667	-
O	1667	1669	20
O	1669	1670	.
O	1670	1671	7
O	1671	1672	°
O	1672	1673	]
O	1673	1674	,
B-outcome	1675	1683	external
I-outcome	1684	1692	rotation
I-outcome	1693	1695	at
I-outcome	1696	1697	0
I-outcome	1697	1698	°
O	1699	1700	=
O	1701	1703	23
O	1703	1704	.
O	1704	1705	4
O	1705	1706	°
O	1707	1708	[
O	1708	1710	95
O	1710	1711	%
O	1712	1714	CI
O	1715	1716	=
O	1717	1719	31
O	1719	1720	.
O	1720	1721	1
O	1721	1722	-
O	1722	1724	12
O	1724	1725	.
O	1725	1726	5
O	1726	1727	°
O	1727	1728	]
O	1728	1729	,
O	1730	1733	and
B-outcome	1734	1742	external
I-outcome	1743	1751	rotation
I-outcome	1752	1754	at
I-outcome	1755	1757	90
I-outcome	1757	1758	°
O	1759	1760	=
O	1761	1763	34
O	1763	1764	.
O	1764	1765	3
O	1765	1766	°
O	1767	1768	[
O	1768	1770	95
O	1770	1771	%
O	1772	1774	CI
O	1775	1776	=
O	1777	1779	45
O	1779	1780	.
O	1780	1781	9
O	1781	1782	-
O	1782	1784	26
O	1784	1785	.
O	1785	1786	2
O	1786	1787	°
O	1787	1788	]
O	1788	1789	)
O	1789	1790	,
B-outcome	1791	1799	improved
I-outcome	1800	1805	upper
I-outcome	1806	1815	extremity
I-outcome	1816	1825	isometric
I-outcome	1826	1834	strength
O	1834	1835	,
O	1836	1839	and
B-outcome	1840	1848	improved
I-outcome	1849	1861	Disabilities
I-outcome	1862	1864	of
I-outcome	1865	1868	the
I-outcome	1869	1872	Arm
I-outcome	1872	1873	,
I-outcome	1874	1882	Shoulder
I-outcome	1882	1883	,
I-outcome	1884	1887	and
I-outcome	1888	1892	Hand
I-outcome	1893	1896	and
I-outcome	1897	1901	Penn
I-outcome	1902	1910	Shoulder
I-outcome	1911	1916	Scale
I-outcome	1917	1923	scores
O	1923	1924	.

O	1925	1936	Limitations
O	1937	1944	include
O	1945	1946	a
O	1947	1951	lack
O	1952	1954	of
O	1955	1962	masking
O	1963	1965	of
O	1966	1975	assessors
O	1976	1981	after
O	1982	1985	the
O	1986	1998	intervention
O	1998	1999	,
O	2000	2002	an
O	2003	2012	attention
O	2013	2020	control
O	2021	2026	group
O	2026	2027	,
O	2028	2031	and
O	2032	2043	statistical
O	2044	2054	robustness
O	2055	2056	(
B-outcome-Measure	2056	2064	shoulder
I-outcome-Measure	2065	2073	function
O	2074	2077	was
O	2078	2079	a
O	2080	2089	secondary
O	2090	2093	end
O	2094	2099	point
O	2099	2100	)
O	2100	2101	.

O	2102	2103	A
O	2104	2106	16
O	2106	2107	-
O	2107	2111	week
O	2112	2120	exercise
O	2121	2133	intervention
O	2134	2145	effectively
O	2146	2154	improved
O	2155	2163	shoulder
O	2164	2172	function
O	2173	2182	following
O	2183	2189	breast
O	2190	2196	cancer
O	2197	2206	treatment
O	2207	2209	in
O	2210	2215	women
O	2216	2219	who
O	2220	2224	were
O	2225	2235	overweight
O	2236	2238	or
O	2239	2244	obese
O	2244	2245	,
O	2246	2249	who
O	2250	2254	were
O	2255	2265	ethnically
O	2266	2273	diverse
O	2273	2274	,
O	2275	2278	and
O	2279	2282	who
O	2283	2286	had
O	2287	2293	breast
O	2294	2300	cancer
O	2300	2301	.
